Assignee
EXCALIARD PHARMACEUTICALS INC
US·1 granted patent·3 pending applications·0 citations·filing 2015–2018
Top patents by PatentIndex Score
4 records- 0159US2019323013A1Antisense oligonucleotides directed against connective tissue growth factor and uses thereofEXCALIARD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0255US2017335329A1Antisense oligonucleotides directed against connective tissue growth factor and uses thereofEXCALIARD PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0352US9688987B2Antisense oligonucleotides directed against connective tissue growth factor and uses thereofEXCALIARD PHARMACEUTICALS INC·Filed 2015·Granted Jun 27, 2017·0 cites·59 claims
- 0437US2017022501A1Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (ctgf)EXCALIARD PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EXCALIARD PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →